GlassScriptPhysician profile
Luann M Thayer
NPI 1629053764
$2,742.52
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $931 · 2022: $1,133 · 2023: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $678.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $323.70 | 2021-2022 | |
| Astellas Pharma US INC | $248.12 | 2021-2023 | Myrbetriq, Xtandi |
| Pfizer INC. | $238.38 | 2021-2023 | |
| Dentsply Ih INC. | $197.24 | 2022 | |
| Antares Pharma, INC. | $176.10 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Abbvie INC. | $163.79 | 2021-2023 | |
| Medtronic, INC. | $143.31 | 2021-2022 | |
| Coloplast Corp | $117.15 | 2021-2023 | Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $109.24 | 2021-2023 | |
| Janssen Biotech, INC. | $98.94 | 2021-2023 | Erleada |
| Tolmar Pharmaceuticals, INC. | $90.94 | 2021 | |
| 180 Medical, INC. | $89.99 | 2022-2023 | Gentlecath Glide, Gentlecath |
| Clarus Therapeutics INC. | $82.40 | 2021 | |
| Sumitomo Pharma America, INC. | $73.68 | 2023 | Gemtesa, Orgovyx |
| Merck Sharp & Dohme LLC | $56.93 | 2023 | Keytruda, Lynparza |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $54.20 | 2021-2023 | Xiaflex |
| Halozyme INC | $52.12 | 2023 | |
| Myovant Sciences INC. | $49.19 | 2021 | |
| Olympus America INC. | $48.67 | 2023 | Itind System |
| Urogen Pharma, INC. | $42.39 | 2022-2023 | Jelmyto |
| Telix Pharmaceuticals | $34.47 | 2022-2023 | Illuccix |
| Myriad Genetic Laboratories, INC. | $33.41 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $31.99 | 2022-2023 | Seglentis |
| Teleflex LLC | $30.34 | 2022-2023 | Urolift |
| Smith+Nephew, INC. | $24.35 | 2022 | |
| Boston Scientific Corporation | $21.57 | 2023 | |
| Axonics, INC. | $21.12 | 2021 | |
| Braintree Laboratories, INC. | $20.79 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $18.41 | 2022 | |
| Dendreon Pharmaceuticals LLC | $17.20 | 2023 | Provenge |
| Innocoll Pharmaceuticals Limited | $16.98 | 2022 | |
| Allergan, INC. | $15.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luann Thayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.